Finance

Lists
Why is 688578 up 3.50%?
Dive Deeper
688578:SHA
Shanghai Allist Pharmaceuticals Co Ltd
CN¥85.99
+3.50%
(+2.91) 1D
Nov 4, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688578...
Open
CN¥83.60
High
CN¥87.60
Low
CN¥82.80
Mkt. cap
37.39B
Avg. vol.
8.24M
Volume
8.50M
Dividend
1.40%
Quarterly dividend
CN¥0.30
Ex-dividend date
Sep 2, 2026
P/E ratio
13.31
52-wk high
CN¥138.30
52-wk low
CN¥75.55
EPS
CN¥6.46
No. of employees
2K
Open
CN¥83.60
High
CN¥87.60
Low
CN¥82.80
Mkt. cap
37.39B
Avg. vol.
8.24M
Volume
8.50M
Dividend
1.40%
Quarterly dividend
CN¥0.30
Ex-dividend date
Sep 2, 2026
P/E ratio
13.31
52-wk high
CN¥138.30
52-wk low
CN¥75.55
EPS
CN¥6.46
No. of employees
2K
News stories
From web sources and news partners
About Shanghai Allist Pharmaceuticals Co Ltd
CEO-
Employees2.27K
FoundedMar 22, 2004
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteallist.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.45B
1.58B
1.74B
1.82B
Cost of goods sold
44.82M
80.59M
90.24M
91.37M
Cost of revenue
44.82M
80.59M
90.24M
91.37M
Research and development expenses
100.54M
113.72M
112.11M
153.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
651.83M
646.12M
667.07M
676.13M
Operating expense
771.29M
779.22M
805.13M
616.42M
Total operating expenses
816.11M
859.80M
895.38M
707.79M
Operating income
638.21M
723.97M
840.64M
1.11B
Other non operating income
2.18M
-4.07M
4.51M
-11.69M
EBT including unusual items
656.24M
741.46M
1.06B
924.61M
EBT excluding unusual items
652.61M
742.22M
861.81M
1.13B
Income tax expense
82.91M
105.41M
154.67M
132.13M
Effective tax rate
12.63%
14.22%
14.60%
14.29%
Other operating expenses
18.97M
20.01M
24.71M
-212.64M
Net income
573.33M
636.04M
904.75M
792.48M
Net profit margin
39.42%
40.16%
52.12%
43.65%
Earnings per share
-
-
-
-
Interest and investment income
17.89M
22.35M
25.93M
24.17M
Interest expense
-9.69K
-34.43K
-31.50K
-29.83K
Net interest expenses
17.88M
22.32M
25.90M
24.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
648.03M
733.79M
852.49M
1.12B
Gain or loss from assets sale
-23.20K
-
-6.73K
6.73K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps